Meeting with Government and Healthcare officials to discuss pharmaceutical and health policy, economic development as it relates to clinical trials and other research, scientific information related to GSK's portfolio of medicines and vaccines.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19, Economic Development and Trade, Health, Hospitals, Intellectual Property, Science and Technology
|